Goodbody Health Stock Return On Equity

Goodbody Health fundamentals help investors to digest information that contributes to Goodbody Health's financial success or failures. It also enables traders to predict the movement of Goodbody OTC Stock. The fundamental analysis module provides a way to measure Goodbody Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Goodbody Health otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Goodbody Health OTC Stock Return On Equity Analysis

Goodbody Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Goodbody Health Return On Equity

    
  -0.56  
Most of Goodbody Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Goodbody Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Goodbody Health has a Return On Equity of -0.5554. This is 97.68% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 79.16% higher than that of the company.

Goodbody Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Goodbody Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Goodbody Health could also be used in its relative valuation, which is a method of valuing Goodbody Health by comparing valuation metrics of similar companies.
Goodbody Health is currently under evaluation in return on equity category among its peers.

Goodbody Fundamentals

About Goodbody Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Goodbody Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Goodbody Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Goodbody Health based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Goodbody OTC Stock

Goodbody Health financial ratios help investors to determine whether Goodbody OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goodbody with respect to the benefits of owning Goodbody Health security.